Fortress Biotech, Inc.

NASDAQ:FBIO

Biotechnology

Healthcare
$1.89 -1.79%

-$0.06 today

Market cap
$63.03M
Beta
1.23
P/E (TTM)
0.7
EPS (TTM)
$4.05
52W Low $1.70High $4.53

Volume 0.41M

Average 0.43M

FBIO Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Fortress Biotech, Inc.NASDAQ: FBIO

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) grows, but more slowly than its trailing trend

Q1 FY2026 weighted avg shares (diluted) of 38.41M shares rose 45.2% year over year, behind the +349.0% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 86.2% from the prior quarter. Over 3 fiscal years it compounded at +261.1% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +45.2% toward the trailing-twelve-month pace of +349.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
38.41M-86.2% QoQ
Last fiscal yearDec 2025
279.02M+1242.5% YoY
LTMMar 2026
95.09M+349.0% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+45.2%——
1 year+1242.5%——
3-year CAGR+261.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
279.02M USD
Year-over-year change
+1242.5%
4-year CAGR
+167.5%

Weighted Avg Shares (Diluted) vs competitors

How FBIO compares with its peers on the latest reported figures

  • FBIO's LTM Mar 2026 weighted avg shares (diluted) of 95.09M shares is the 3rd highest of the 10 companies compared; the peer median is 35.23M shares.
  • Its year-over-year change of +349.0% is the highest of 9, against a peer median of +11.6%.
  • Over three fiscal years its annual growth of +261.1% compares with a peer median of +10.0%.
FBIO Competitors Peer median
Weighted Avg Shares (Diluted) for FBIO and competitors
Company Period LTM YoY 3-year CAGR
VXRTVaxart, Inc.LTM Mar 2026232.46M +14.7%-22.1%
TCRXTScan Therapeutics, Inc.LTM Mar 2026129.84M +7.6%+75.4%
FBIOFortress Biotech, Inc.LTM Mar 202695.09M +349.0%+261.1%
RLMDRelmada Therapeutics, Inc.LTM Mar 202655.31M +82.9%+10.0%
PMVPPMV Pharmaceuticals, Inc.LTM Mar 202652.9M +2.4%+4.8%
ADAGAdagene Inc.LTM Jun 202435.23M —+2.9%
GANXGain Therapeutics, Inc.LTM Mar 202635.13M +38.4%+40.5%
XBITXBiotech Inc.LTM Mar 202630.49M +0.1%+0.1%
IMUXImmunic, Inc.LTM Mar 202619.58M +98.7%+69.8%
NTRBNutriband Inc.LTM Apr 202611.9M +8.4%+11.2%
Peer median (excluding FBIO) 35.23M+11.6%+10.0%

Competitors are the stored peer set for FBIO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue68.79M75.74M84.51M57.68M63.26M
Cost of Revenue32.08M30.78M22.89M20.88M20.92M
Gross Profit36.71M44.97M61.62M36.8M42.34M
Gross Margin53.4%59.4%72.9%63.8%66.9%
Research & Development128.87M134.88M106.07M56.88M11.9M
Selling, General & Admin86.84M113.66M90.98M87.73M96.4M
Operating Expenses225.25M248.53M203.96M147.18M112.56M
Depreciation & Amortization6.79M9.35M6M4.46M4.66M
EBITDA(146.17M)(193.69M)(135.72M)(104.49M)(20.17M)
EBITDA Margin-212.5%-255.7%-160.6%-181.2%-31.9%
Operating Income(188.54M)(203.56M)(142.34M)(110.38M)(70.22M)
Operating Margin-274.1%-268.8%-168.4%-191.4%-111.0%
Interest Income649K1.4M3M2.68M2.49M
Interest Expense15.31M13.64M12.52M9.93M8.71M
Other Income / Expenses24.19M(9.9M)(11.29M)(10.16M)36.69M
Income Before Tax(164.35M)(213.46M)(153.63M)(120.54M)(33.54M)
Pre-Tax Margin-238.9%-281.8%-181.8%-209.0%-53.0%
Income Tax Expense473K449K521K312K(620K)
Net Income(64.7M)(86.58M)(60.64M)(46M)6.82M
Net Margin-94.1%-114.3%-71.7%-79.8%10.8%
EPS (Basic)(11.85)(14.55)(8.47)(2.69)(0.07)
EPS (Diluted)(11.85)(14.55)(8.47)(2.69)(0.07)
Weighted Avg Shares5.45M5.93M8.11M20.78M27.9M
Weighted Avg Shares (Diluted)5.45M5.93M8.11M20.78M279.02M

Fortress Biotech, Inc.

NASDAQ:FBIO

Intrinsic Alpha fair value

Locked

Current Price

$1.89

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.